Experienced in Vitiligo

Dr. Joan L. Walker

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Ou Health Partners Inc
900 Ne 10th St, Ouhp Family Medicine, 
Oklahoma City, OK 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
43 Years of Experience
Experienced in Vitiligo
Ou Health Partners Inc
900 Ne 10th St, Ouhp Family Medicine, 
Oklahoma City, OK 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joan Walker is a Gynecologic Oncologist and an Oncologist in Oklahoma City, Oklahoma. Dr. Walker has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Vitiligo. Her top areas of expertise are Ovarian Cancer, Cervical Cancer, Endometrial Cancer, Hysterectomy, and Endoscopy. Dr. Walker is currently accepting new patients.

Her clinical research consists of co-authoring 165 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1982
Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in OK
Hospital Affiliations
Ssm Health St Anthony Hospital - Shawnee
O U Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
GlobalHealth
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

OU HEALTH PARTNERS INC
900 Ne 10th St, Ouhp Family Medicine, Oklahoma City, OK 73104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2025
Intervention Type: Drug, Procedure
Study Drugs: Carboplatin, Letrozole, Paclitaxel
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell Immunotherapy in Subjects With Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell Immunotherapy in Subjects With Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: June 05, 2025
Intervention Type: Other, Biological
Study Drug: Vigil
Study Phase: Phase 2
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA Cervical Cancer Treated With Initial Radical Hysterectomy and Pelvic Lymphadenectomy (NCT #01101451)
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Cisplatin
Study Phase: Phase 3
A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy Versus Abdominal Radical Hysterectomy in Patients With Early Stage Cervical Cancer
A Phase III Randomized Clinical Trial of Laparoscopic or Robotic Radical Hysterectomy Versus Abdominal Radical Hysterectomy in Patients With Early Stage Cervical Cancer
Enrollment Status: Completed
Publish Date: April 18, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase III Clinical Trial of Bevacizumab With IV Versus IP Chemotherapy in Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
A Phase III Clinical Trial of Bevacizumab With IV Versus IP Chemotherapy in Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Enrollment Status: Completed
Publish Date: May 04, 2021
Intervention Type: Other, Drug, Biological
Study Phase: Phase 3
View 5 Less Clinical Trials

165 Total Publications

The promise and translation of cell-free human papillomavirus DNA testing for cervical cancer surveillance.
The promise and translation of cell-free human papillomavirus DNA testing for cervical cancer surveillance.
Journal: Translational cancer research
Published: January 29, 2025
Similar Doctors
Advanced in Vitiligo
Dr. Benjamin J. Barenberg
Obstetrics and Gynecology
Advanced in Vitiligo
Dr. Benjamin J. Barenberg
Obstetrics and Gynecology

Optimal Health Associates LLC

9800 Broadway Ext, Suite 200, 
Oklahoma City, OK 
 (6.4 miles away)
405-715-4496
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Benjamin Barenberg is an Obstetrics and Gynecologist in Oklahoma City, Oklahoma. Dr. Barenberg is rated as an Advanced provider by MediFind in the treatment of Vitiligo. His top areas of expertise are Urinary Incontinence, Menopause, Stress Urinary Incontinence, Opisthotonos, and Intrauterine Device Insertion. Dr. Barenberg is currently accepting new patients.

Advanced in Vitiligo
Dr. Stephanie A. White-Carter
Obstetrics and Gynecology
Advanced in Vitiligo
Dr. Stephanie A. White-Carter
Obstetrics and Gynecology

Norman Regional Health System

3300 HealthPlex Parkway, 
Norman, OK 
 (15.1 miles away)
405-307-1000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Stephanie White-Carter is an Obstetrics and Gynecologist in Norman, Oklahoma. Dr. White-Carter is rated as an Advanced provider by MediFind in the treatment of Vitiligo. Her top areas of expertise are Menorrhagia, Painful Menstrual Periods, Neonatal Ovarian Cyst, Ovarian Cysts, and Intrauterine Device Insertion. Dr. White-Carter is currently accepting new patients.

Experienced in Vitiligo
Dr. Arielle M. Allen
Obstetrics and Gynecology
Experienced in Vitiligo
Dr. Arielle M. Allen
Obstetrics and Gynecology

Urogynecology Of Oklahoma, PLLC

11100 Hefner Pointe Dr, Suite B, 
Oklahoma City, OK 
 (8.7 miles away)
405-400-8188
Languages Spoken:
English, French, Mandarin, Spanish
See accepted insurances
Accepting New Patients

Arielle Allen is an Obstetrics and Gynecologist in Oklahoma City, Oklahoma. Dr. Allen is rated as a Distinguished provider by MediFind in the treatment of Vitiligo. Her top areas of expertise are Rectocele, Urinary Incontinence, Stress Urinary Incontinence, and Vaginismus. Dr. Allen is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Walker's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 15 Advanced Conditions
View All 43 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile